In September, the FDA approved topical ruxolitinib cream (Opzelura, Incyte) as the first JAK inhibitor to treat AD. Del Rosso noted its list of indications could expand in the near future. Recently released Phase 3 clinical trial program data shows positive outcomes for this JAK inhibitor in treating vitiligo and AA.
New Treatment Options
Resources for Dermatologist treating patients with Vitiligo in Florida
Are you looking for a dermatologist to treat your vitiligo? Are you located in Central Florida area?
Click on the link below to schedule an appointment with Dr. Seth Forman our medical advisor's practice is located in the Tampa area.
AS SEEN ON
https://www.youtube.com/watch?v=_RjyQuYtggo&t=193s June 16, 2022
Beautifully Unblemished | WFLA February 27, 2020
August 17, 2019
March 13, 2019